BDMD - CIK 0001982444
The table below shows Baird Medical Investment Holdings Ltd's income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $22.54M | $37.04M | $31.46M | $35.09M |
| Cost of revenue | $3.65M | $4.38M | $4.23M | $7.05M |
| Gross profit | $18.88M | $32.65M | $27.23M | $28.04M |
| R&D | $20.13M | $6.17M | $4.27M | $3.86M |
| SG&A | $14.12M | $7.10M | $8.55M | $6.96M |
| Operating income | -$25.63M | $15.32M | $11.86M | $13.63M |
Baird Medical Investment Holdings Ltd reported annual revenue of $22.54M for fiscal year 2025. That is down 39.2% from $37.04M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Income tax | $1.17M | $1.49M | $1.70M | $1.75M |
| Net income | -$27.28M | $12.45M | $10.55M | - |
| EPS (diluted) | -$0.98 | $0.57 | $0.51 | $0.49 |